Heterologous Expression of Epoxomicin in Escherichia coli

Sarah R. Messenger,David F. Ackerley,Mark J. Calcott
DOI: https://doi.org/10.1021/acssynbio.4c00430
IF: 5.249
2024-08-10
ACS Synthetic Biology
Abstract:Epoxomicin is an epoxyketone proteasome inhibitor with synthetic derivatives approved or under investigation for treatment of multiple myeloma. To leverage the advantages of Escherichia coli as a rapidly growing and readily engineered host for the production of epoxomicin and analogues, we expressed codon-optimized versions of the epoxomicin biosynthetic genes, epxD, epxE, and epxF. Epoxomicin was detected, but the major product was a ketone resulting from α,β-keto acid precursor...
biochemical research methods
What problem does this paper attempt to address?